Apigenin, a potent suppressor of dendritic cell maturation and migration, protects against collagen-induced arthritis

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 1, 2016, Pages 170-180

  Li, Xing ^a,b   Han, Yanping ^a,b,c   Zhou, Qingyou ^a,b   Jie, Hongyu ^a,b   He, Yi ^a,b   Han, Jiaochan ^a,b   He, Juan ^a,b   Jiang, Yong ^d   Sun, Erwei ^a,b  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^b Academy of Orthopedics   (China)

^c SOUTH CHINA NORMAL UNIVERSITY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Apigenin; Dendritic cells; Maturation; Migration; Rheumatoid arthritis

Indexed keywords

APIGENIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; COLLAGEN TYPE 2; CXCR4 PROTEIN, MOUSE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTHRITIS; ARTICLE; CELL MATURATION; CELL MIGRATION; CHEMOTAXIS ASSAY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BLOOD; C57BL MOUSE; CELL CULTURE; CELL MOTION; DBA MOUSE; DRUG EFFECTS; IMMUNOLOGY; LYMPH NODE; PHYSIOLOGY;

ANIMALS; APIGENIN; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN TYPE II; CYTOKINES; DENDRITIC CELLS; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LYMPH NODES; MALE; MICE, INBRED C57BL; MICE, INBRED DBA; RECEPTORS, CXCR4;

EID: 84956592746     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12717     Document Type: Article

References (41)

1. Weyand CM. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology. 2000; 39: 3-8.
2. Ganguly D, Haak S, Sisirak V, et al. The role of dendritic cells in autoimmunity. Nat Rev Immunol. 2013; 13: 566-77.
3. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003; 423: 356-61.
4. Lutzky V, Hannawi S, Thomas R. Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res Ther. 2007; 9: 219.
5. Wenink MH, Han W, Toes RE, et al. Dendritic cells and their potential implication in pathology and treatment of rheumatoid arthritis. Handb Exp Pharmacol. 2009; 188: 81-98.
6. Lebre MC, Jongbloed SL, Tas SW, et al. Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles. Am J Pathol. 2008; 172: 940-50.
7. Steinman RM. Dendritic cells and immune-based therapies. Exp Hematol. 1996; 24: 859-62.
8. Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res. 2010; 27: 962-78.
9. Liang YC, Huang YT, Tsai SH, et al. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 1999; 20: 1945-52.
10. Lee JH, Zhou HY, Cho SY, et al. Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Arch Pharm Res. 2007; 30: 1318-27.
11. Kang HK, Ecklund D, Liu M, et al. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res Ther. 2009; 11: R59.
12. Li J, Zhang B. Apigenin protects ovalbumin-induced asthma through the regulation of Th17 cells. Fitoterapia. 2013; 91: 298-304.
13. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992; 176: 1693-702.
14. Yu YL, Chen IH, Shen KY, et al. A triterpenoid methyl antcinate K isolated from Antrodia cinnamomea promotes dendritic cell activation and Th2 differentiation. Eur J Immunol. 2009; 39: 2482-91.
15. Huang RY, Yu YL, Cheng WC, et al. Immunosuppressive effect of quercetin on dendritic cell activation and function. J Immunol. 2010; 184: 6815-21.
16. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007; 2: 1269-75.
17. Sarkar S, Cooney LA, White P, et al. Regulation of pathogenic IL-17A responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther. 2009; 11: R158.
18. Alvarez D, Vollmann EH, von Andrian UH. Mechanisms and consequences of dendritic cell migration. Immunity. 2008; 29: 325-42.
19. Walsh NC, Crotti TN, Goldring SR, et al. Rheumatic diseases: the effects of inflammation on bone. Immunol Rev. 2005; 208: 228-51.
20. Khan S, Greenberg JD, Bhardwaj N. Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol. 2009; 5: 566-71.
21. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol. 1994; 152: 2613-23.
22. Leung BP, Conacher M, Hunter D, et al. A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation. J Immunol. 2002; 169: 7071-7.
23. Sato A, Iwasaki A. Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc Natl Acad Sci USA. 2004; 101: 16274-9.
24. Gay NJ, Gangloff M, Weber AN. Toll-like receptors as molecular switches. Nat Rev Immunol. 2006; 6: 693-8.
25. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004; 5: 987-95.
26. Kaisho T, Tanaka T. Turning NF-kappaB and IRFs on and off in DC. Trends Immunol. 2008; 29: 329-36.
27. Zaru R, Ronkina N, Gaestel M, et al. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat Immunol. 2007; 8: 1227-35.
28. Mounho BJ, Thrall BD. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro. Toxicol Appl Pharmacol. 1999; 159: 125-33.
29. Seo HS, Choi HS, Kim SR, et al. Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFkappaB signaling in HER2-overexpressing breast cancer cells. Mol Cell Biochem. 2012; 366: 319-34.
30. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998; 392: 245-52.
31. Ratzinger G, Stoitzner P, Ebner S, et al. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol. 2002; 168: 4361-71.
32. Yen JH, Khayrullina T, Ganea D. PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood. 2008; 111: 260-70.
33. Gunn MD, Kyuwa S, Tam C, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med. 1999; 189: 451-60.
34. Johnson LA, Clasper S, Holt AP, et al. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med. 2006; 203: 2763-77.
35. Lefort EC, Blay J. Apigenin and its impact on gastrointestinal cancers. Mol Nutr Food Res. 2013; 57: 126-44.
36. Lindenmeyer F, Li H, Menashi S, et al. Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr Cancer. 2001; 39: 139-47.
37. Piantelli M, Rossi C, Iezzi M, et al. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. J Cell Physiol. 2006; 207: 23-9.
38. Wang L, Kuang L, Hitron JA, et al. Apigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expression. Toxicol Appl Pharmacol. 2013; 272: 108-16.
39. Randolph GJ, Ochando J, Partida-Sánchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol. 2008; 26: 293-316.
40. Burska A, Boissinot M, Ponchel F. Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm. 2014; 54: 54-93.
41. Myers LK, Rosloniec EF, Cremer MA, et al. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997; 61: 1861-78.